19219-89-7

Upstream product

• 40463-12-5 5-methyl-5-phenylhex-1-ene 
• 625-23-0 2-methylhexan-2-ol 
• 71-43-2 benzene 
• 1009-14-9 phenyl butyl ketone 
• 544-97-8 dimethyl zinc(II) 
• 98-83-9 isopropenylbenzene 
• 7446-70-0 aluminium trichloride 
• 7647-01-0 hydrogenchloride 
• 617-29-8 2-methylhexan-3-ol 
• 4398-65-6 2-chloro-2-methylhexane 
• 693-03-8 n-butyl magnesium bromide 
• 3575-19-7 2-bromo-2-phenylpropane 
• 106-98-9 1-butylene 
• 98-82-8 Isopropylbenzene 

Downstream Products

• 873421-53-5 1-(1,1-dimethyl-pentyl)-4-nitro-benzene 
• 67467-90-7 3-[p-(1,1-dimethyl-pentyl)-phenyl]-2-methyl-propionaldehyde 
• 873412-61-4 4-(1,1-dimethyl-pentyl)-aniline 
• 30784-31-7 4-(1,1-Dimethyl-pentyl)-phenol 
• 1027252-38-5 1,3-Bis<<4-(1,1-dimethylpentyl)pheny>thio>-4,6-dinitrobenzene 
• 155059-92-0 4-(1,1-Dimethylpentyl)thiophenol 
• 155059-91-9 4-(1,1-Dimethylpentyl)benzenesulfonyl chloride 

Relevant academic research and scientific papers

QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR

This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to quinoline-derived amides that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.

Novel Donor 1,4-Benzothiazinophenothiazine

The synthesis of the novel organic donor 1,4-benzothiazinophenothiazine (3) via a double Cadogan-type ring closure is reported.The target molecule is characterized by a 1H NOE-spectrum and by X-ray analysis, thus confirming the "migration" of the l